Zeng Li Yang
Chief Executive Officer bei AUTOBIO DIAGNOSTICS CO., LTD.
Aktive Positionen von Zeng Li Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AUTOBIO DIAGNOSTICS CO., LTD. | Director/Board Member | 13.11.2012 | - |
Chief Executive Officer | 29.10.2018 | - | |
Corporate Officer/Principal | 13.11.2012 | 29.10.2018 | |
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Director/Board Member | - | - |
Karriereverlauf von Zeng Li Yang
Statistik
International
China | 3 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AUTOBIO DIAGNOSTICS CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Autobio Biochemistry Co., Ltd.
Autobio Biochemistry Co., Ltd. Medical SpecialtiesHealth Technology Beijing Bio-Top Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostics. Its products include hydroxy vitamin D, anti cyclic citrullinated peptide, heart fatty acid binding protein, procalcitonin, neutrophil gelatinase associated lipocalin, prospepsin, cardiac troponin 1, myoglobin, nonesterified free fatty acid, and cholyglycine. The company was founded on October 20, 2009 and is headquartered in Beijing, China. | Health Technology |
- Börse
- Insiders
- Zeng Li Yang
- Erfahrung